sglt2 glp 1 combination Complementary Yet Distinct Roles of GLP-1 Receptor Agonists and Inhibitors in Cardiovascular Risk Reduction GLP-1 Receptor Agonists and SGLT2

See who qualifies

By Vital Nutrients

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a pivotal treatment option for both conditions, ...

Discover why GLP-1 medications like semaglutide and liraglutide can cause a bad taste in your mouth, how long it lasts, which drugs are most affected, and practical strategies to manage this side effect during diabetes or weight management treatment.

Scott Harris, M.D., will be discussing the promise of #GLP1/#Glucagon approaches in treating #MASH and #MASLD, as well as the importance of developing therapies tailored to the specific needs of patients with #obesity and/or #MASH

report here on a GIPR antagonist conjugated to GLP-1 analogues that reduces body weight and improves metabolic markers in preclinical and phase 1 clinical settings.